SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

TREM2-Expressing Microglia

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-trem2-expressing-microgl
Related Entities
cell-types-trem2-expressing-microglia
Metadata
slugcell-types-trem2-expressing-microglia
entity_typecell
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (184)
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia90%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination80%
mentions🧪TREM2-mediated microglial tau clearance enhancement80%
mentions🔬Immune atlas neuroinflammation analysis in neurodegeneration75%
mentions🔬Neuroinflammation and microglial priming in early Alzheimer&75%
mentions🔬Neuroinflammation and microglial priming in early AD — Analy75%
mentions🔬Does SYK activation provide neuroprotection or exacerbate ne75%
mentions🔬What are the optimal timing windows for TREM2 agonism vs ant75%
mentions🔬Analysis question not specified75%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination70%
mentions🧪TREM2-mediated microglial tau clearance enhancement70%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia70%
mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam70%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro70%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro70%
mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional70%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%
mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
mentions🧫Experiment: Autoimmune Hypothesis Testing in AD70%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%
mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
mentions🧫DLB Cognitive Fluctuation Mechanism Experiment70%
mentions🧫Genetic Risk Modifiers in DLB Phenotype70%
mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras70%
mentions🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
mentions🧫Microglial Contributions to Huntington's Disease Pathog70%
mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress70%
mentions🧫Prodromal Parkinson's Disease Biomarker Development — E70%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%
mentions🧫PSP and CBS Biomarker Validation Study70%
mentions🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo70%
mentions🧫Experiment Validation: In vitro ThT Assay70%
mentions🧫Tau ASO Therapy70%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy70%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim70%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%
related🧫Microglial TREM2 Agonist In Vivo Efficacy70%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim70%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%
related🧪APOE-TREM2 Interaction Modulation70%
related🔬Immune atlas neuroinflammation analysis in neurodegeneration67%
related🔬Neuroinflammation and microglial priming in early Alzheimer&67%
related🔬Neuroinflammation and microglial priming in early AD — Analy67%
related🔬Does SYK activation provide neuroprotection or exacerbate ne67%
related🔬What are the optimal timing windows for TREM2 agonism vs ant67%
related🔬Analysis question not specified67%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination63%
related🧪TREM2-mediated microglial tau clearance enhancement63%
related🧫s:** - GPR32 knockout in microglia should worsen neuroinflam63%
related🧫Proposed experiment from debate on Synaptic pruning by micro63%
related🧫Proposed experiment from debate on Synaptic pruning by micro63%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional63%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%
related🧫Experiment: Autoimmune Hypothesis Testing in AD63%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring63%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%
related🧫DLB Cognitive Fluctuation Mechanism Experiment63%
related🧫Genetic Risk Modifiers in DLB Phenotype63%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras63%
related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud63%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%
related🧫Microglial Contributions to Huntington's Disease Pathog63%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress63%
related🧫Prodromal Parkinson's Disease Biomarker Development — E63%
related🧫Progranulin Replacement Therapy for FTD — Vector Development63%
related🧫PSP and CBS Biomarker Validation Study63%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo63%
related🧫Experiment Validation: In vitro ThT Assay63%
related🧫Tau ASO Therapy63%
related🧫Microglial TREM2 Agonist In Vivo Efficacy63%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim63%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer60%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides60%
mentions🧪Competitive APOE4 Domain Stabilization Peptides60%
mentions🧪APOE-TREM2 Interaction Modulation60%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway60%
mentions🧪TREM2-Dependent Microglial Senescence Transition60%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR60%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR60%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen60%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer54%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides54%
related🧪Competitive APOE4 Domain Stabilization Peptides54%
related🧪APOE-TREM2 Interaction Modulation54%
related🧪TREM2-Mediated Selective Aggregate Clearance Pathway54%
related🧪TREM2-Dependent Microglial Senescence Transition54%
related🔬The disease-associated microglia (DAM) phenotype involves TR54%
related🔬The disease-associated microglia (DAM) phenotype involves TR54%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen54%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
mentions🧪APOE-Dependent Autophagy Restoration50%
mentions🧪Senescent Cell Mitochondrial DNA Release50%
mentions🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem50%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%
mentions🧪Synthetic Biology BBB Endothelial Cell Reprogramming50%
mentions🧪Senescent Microglia Resolution via Maresins-Senolytics Combi50%
mentions🧪Orexin-Microglia Modulation Therapy50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬Analyze the spectrum of microglial activation states (DAM, h50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea50%
related🔬Senolytics targeting p16/p21+ senescent astrocytes and micro50%
related🔬Synaptic pruning by microglia in early AD50%
related🧪APOE Isoform Conversion Therapy50%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
see_also📖sTREM2 (Soluble TREM2) - Microglial Biomarker50%
see_also📖sTREM2 (Soluble TREM2) - Biomarker50%
see_also📖al002-trem2-agonist-alzheimers50%
see_also📖TREM2 Gene50%
see_also📖TREM2 in Amyotrophic Lateral Sclerosis45%
see_also📖TREM2 in Frontotemporal Dementia45%
see_also📖TREM2 Gene-Mechanism-Therapy Chain — From Genetic Risk to Th45%
mentions🔬Microglia activate astrocytes via IL-1alpha/TNF/C1q, and rea40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%
mentions🔬What are the mechanisms underlying synaptic pruning by micro40%
mentions🔬Analyze the spectrum of microglial activation states (DAM, h40%
mentions🔬Senolytics targeting p16/p21+ senescent astrocytes and micro40%
mentions🔬Synaptic pruning by microglia in early AD40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi40%
related🧪Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancem40%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%
related🧪Synthetic Biology BBB Endothelial Cell Reprogramming40%
related🧪Orexin-Microglia Modulation Therapy40%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination35%
related🧪Senescent Microglia Resolution via Maresins-Senolytics Combi35%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia35%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro35%
related🔬What are the mechanisms underlying selective vulnerability o30%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub